Specialty chemical companies have continued to do alright this year, as
volumes and pricing have helped partly offset increasing raw material
pressures. Innospec (IOSP)
has been a bit of a laggard since May, though, with the company’s
second quarter report hurting the share price as investors didn’t like
the weaker than expected margins in the business. I had thought Innospec
looked a little pricey when I last wrote about the company,
but I do see some upside here as I expect the company to benefit from
some lagging pricing actions. If Innospec can get the Oilfield business
in better shape, there could be more meaningful upside.
Read more here:
Innospec Seeing A Hiccup In Margins, But The Core Business Looks On Track
No comments:
Post a Comment